Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland

Abstract

Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland. Acta diabetologica, 57(7),

Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study

“…For individual semi-structured interviews, recruitment was guided by respondents' professional role (to gain different perspectives), and the level of uptake of CSII and experience in CSII (to explore different barriers and facilitators in areas of low and high uptake of CSII). Some participants (endocrinologists, nurses, dietitians working in diabetes clinics) were recruited during data collection for a national survey of the availability of CSII in Ireland [16], and some (policy-makers, patient advocates, insulin pump company representatives, and those from rural areas) through the snowball technique. This method is often used to find and recruit "hidden populations" or groups not easily accessible to researchers through other sampling strategies.…”

“…The reasons behind disparity in the international and national distribution of CSII are not well explored. Results from a national survey of adult diabetes clinics suggest that under-resourcing of diabetes services is a major contributor to the low uptake in Ireland [16], but the determinants of access to diabetes-related technology require further investigation. Some barriers to uptake may be related to preferences of PwD [17,18], or reimbursement strategies [7], as well as lack of specific guidelines and policy documents [19].…”

Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study

“…The scarcity of trained staff, as shown in the survey findings, means that full MDTs were not always available (e.g. lack of dietetic support), and the lack of MDT and perceived work overload were listed as barriers to CSII provision [35]. Another barrier might be related to people with diabetes lack of willingness to be attached to a device and a burden associated with technology use [36,37].…”

Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.

“…The scarcity of trained staff, as shown in the survey ndings, means that full MDTs were not always available (e.g. lack of dietetic support), and the lack of MDT and perceived work overload were listed as barriers to CSII provision [35]. Another barrier might be related to people with diabetes lack of willingness to be attached to a device and a burden associated with technology use [36,37].…”